Harper Hygienics Valuation
Is HRP undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of HRP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate HRP's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate HRP's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HRP?
Other financial metrics that can be useful for relative valuation.
What is HRP's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | zł43.30m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.6x |
Enterprise Value/EBITDA | 8.7x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does HRP's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 18.3x | ||
PHR Pharmena | 2.6x | n/a | zł69.5m |
4MS 4MASS Spólka Akcyjna | 8.6x | n/a | zł165.0m |
DMG Dr. Miele Cosmed Group | 28.8x | n/a | zł305.7m |
S66 Star Combo Pharma | 33.4x | n/a | AU$16.2m |
HRP Harper Hygienics | 99x | n/a | zł43.3m |
Price-To-Earnings vs Peers: HRP is expensive based on its Price-To-Earnings Ratio (99x) compared to the peer average (18.3x).
Price to Earnings Ratio vs Industry
How does HRP's PE Ratio compare vs other companies in the European Personal Products Industry?
Price-To-Earnings vs Industry: HRP is expensive based on its Price-To-Earnings Ratio (99x) compared to the European Personal Products industry average (27.6x).
Price to Earnings Ratio vs Fair Ratio
What is HRP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 99x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate HRP's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.